These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 16394991

  • 1. How new drugs help treat erectile dysfunction.
    Weeks B, Ficorelli CT.
    Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991
    [No Abstract] [Full Text] [Related]

  • 2. Erectile dysfunction.
    Katz A, Katz A.
    CMAJ; 2010 Mar 09; 182(4):381-2. PubMed ID: 20142374
    [No Abstract] [Full Text] [Related]

  • 3. Patient education series. Erectile dysfunction.
    Lewis JH, Rosen R, Goldstein I.
    Nursing; 2005 Feb 09; 35(2):64. PubMed ID: 15706284
    [No Abstract] [Full Text] [Related]

  • 4. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
    Mason RG.
    J R Soc Promot Health; 2003 Jun 09; 123(2):79-80. PubMed ID: 12852189
    [No Abstract] [Full Text] [Related]

  • 5. There have been inadequate warnings that erectile dysfunction drugs can cause blindness.
    Wolfe SM.
    MedGenMed; 2005 Dec 05; 7(4):61. PubMed ID: 16614683
    [No Abstract] [Full Text] [Related]

  • 6. Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active.
    Harv Health Lett; 2014 May 05; 39(7):7. PubMed ID: 25073193
    [No Abstract] [Full Text] [Related]

  • 7. The phosphodiesterase inhibitor 'war'.
    Wyllie MG.
    BJU Int; 2003 Apr 05; 91(6):573-4. PubMed ID: 12656917
    [No Abstract] [Full Text] [Related]

  • 8. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Mulhall JP, McLaughlin TP, Harnett JP, Scott B, Burhani S, Russell D.
    J Sex Med; 2005 Nov 05; 2(6):848-55. PubMed ID: 16422809
    [Abstract] [Full Text] [Related]

  • 9. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
    Briganti A, Salonia A, Deho' F, Zanni G, Barbieri L, Rigatti P, Montorsi F.
    World J Urol; 2005 Dec 05; 23(6):374-84. PubMed ID: 16273417
    [Abstract] [Full Text] [Related]

  • 10. Towards optimal ED management: educational forum - II.
    Brock G.
    Can J Urol; 2001 Dec 05; 8(6):1419-20. PubMed ID: 11799971
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.
    Agarwal P, Sander GE, Giles TD.
    Am J Geriatr Cardiol; 2004 Dec 05; 13(6):332-5. PubMed ID: 15538074
    [No Abstract] [Full Text] [Related]

  • 12. Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'.
    Perimenis P.
    Expert Opin Pharmacother; 2005 Jan 05; 6(1):1-2. PubMed ID: 15709877
    [No Abstract] [Full Text] [Related]

  • 13. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
    Traish A, Kim N.
    J Sex Med; 2008 Jul 05; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
    [No Abstract] [Full Text] [Related]

  • 14. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report.
    Agrawal A, Tutuian R, Hila A, Castell DO.
    Dig Dis Sci; 2005 Nov 05; 50(11):2059-62. PubMed ID: 16240215
    [No Abstract] [Full Text] [Related]

  • 15. The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction.
    Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR, Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A, Endotrial Study Group.
    J Sex Med; 2009 Sep 05; 6(9):2547-60. PubMed ID: 19570039
    [Abstract] [Full Text] [Related]

  • 16. Therapy of ED: PDE-5 Inhibitors.
    Shabsigh R.
    Endocrine; 2004 Sep 05; 23(2-3):135-41. PubMed ID: 15146092
    [Abstract] [Full Text] [Related]

  • 17. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.
    Doggrell SA.
    Expert Opin Pharmacother; 2005 Jan 05; 6(1):75-84. PubMed ID: 15709885
    [Abstract] [Full Text] [Related]

  • 18. [Birthday of a "potency pill". Helmut Newton celebrates posthumously likewise].
    Keil TU.
    MMW Fortschr Med; 2004 Jul 22; 146(29-30):61. PubMed ID: 15540567
    [No Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies.
    McCullough A.
    Curr Urol Rep; 2004 Dec 22; 5(6):451-9. PubMed ID: 15541215
    [Abstract] [Full Text] [Related]

  • 20. Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.
    Fusco F, Sicuteri R, Rossi A, Kontodimas S, Haro JM, Imbimbo C, Mirone V, Italian EDOS Study Group.
    Asian J Androl; 2009 Sep 22; 11(5):629-37. PubMed ID: 19701217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.